(PharmaNewsWire.Com, February 26, 2018 ) The Europe African Horse Sickness Treatment Market was worth USD xx billion in 2016 and estimated to be growing at a CAGR of xx%, to reach USD xx billion by 2021. African horse sickness is caused by a virus of the genus Orbivirus belonging to the family Reoviridae which is highly infectious and deadly disease and it commonly affects horses, mules, and donkeys. This virus is commonly known as African Horse Sickness Virus. It is not directly contagious, but is known to be spread by insect vectors and can be caused by any of the nine serotypes of this virus. This disease has a mortality rate of 95% in horses, which are most susceptible to the disease, while mules and donkeys are less likely to African horse sickness disease.
Good vaccination program is the best preventive method for African horse sickness treatment. In addition, good nutritional program and regular deworming which forms an integral part of horse health. The affected horses are slaughtered usually, where the uninfected horses are vaccinated against the virus. These type of prevention programs are efficient and cost-effective way to prevent common infectious diseases in a horse.
Presence of guidelines and standard operating procedures for African horse sickness disease, rising in research and development programmes for various preventive vaccines, increasing awareness regarding vaccination of horses, rising healthcare infrastructure, increase in disposable income and technology innovations in medical sector are driving the growth of the market. However, multivalent vaccine which do not guarantee that the horses are completely protected from the African horse sickness and high vaccine cost are hampering the growth of the market.
The Europe African Horse Sickness Treatment Market was segmented on the basis of clinical forms, diagnosis and region. On the basis of clinical form, the market is segmented into Dikkop or Cardiac form, Dunkop or Pulmonary form, horse sickness fever, mixed form. Depending on the diagnosis, the market is segmented into prevention treatment and diagnostic tests. The prevention treatment is sub-segmented into vaccines and diagnostic tests is sub-segmented into laboratory tests for viral antigens and serological tests. The laboratory tests for viral antigens segment is further divided into reverse-transcription PCR assays and enzyme-linked immunosorbent assays. The Europe market has been geographically segmented into Germany, U.K, France, Spain, and Italy. In Europe, Germany leads the market, followed by France and U.K. The market in this region is projected to grow strongly during the forecast period due to various factors such as growing awareness and favourable reimbursement policies.
The key players doming the Europe African Horse Sickness Treatment Market are Veterinary Serum and Vaccine Research Institute and Onderstepoort Biological Products SOC Ltd.
Market Segmentation
5.1 Clinical forms 5.1.1 Introduction 5.1.2 Dikkop or Cardiac form 5.1.3 Dunkop or Pulmonary form 5.1.4 Horse sickness fever 5.1.5 Mixed form 5.2 Diagnosis 5.2.1 Introduction 5.2.2 Prevention treatment 5.2.2.1 Vaccines 5.2.3 Diagnostic tests 5.2.3.1 Laboratory tests for viral antigens 5.2.3.2 Serological tests
The scope of the report provides: The evaluation of the current market for your product or services and the future implications of the market Addresses the opportunities by better understanding the market through size estimates and growth rate analysis to forecast the market for the future Extensive segmentation to understand the dynamics of market at a very granular level by splitting down the market to the smallest segment Addresses the key market dynamics involving the drivers, restraints and challenges with an aim of providing insights for gaining market share The factors responsible for the shaping of the industry as it is as a result of competitive environment is analyzed through Porters Five Forces The effects of political, economic, social, technological, legal and environmental factors on the industry is analyzed through PESTLE analysis to better understand the aspects of strategic management required to comply with the exogenous and endogenous factors Strategic evaluation of the key players to gain insights of their performance allowing access to their product portfolio, financial performance and the strengths of their business strategic developments Comparative study of the firms across the industry measuring their performances based on market share and recent activities in order to achieve competitive intelligence
About Us: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and sksillset dedicatedly serve clients from various industries and regions.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
